Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Unresectable Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06345079
What this trial is testing

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Who this might be right for
Neuroendocrine Tumors
Australasian Gastro-Intestinal Trials Group 78
Early research (Phase 1)Ended earlyNCT06364696
What this trial is testing

Find a Suitable Dose of ASP4396 in Adults With Solid Tumors

Who this might be right for
Solid Tumor
Astellas Pharma Inc 60
Early research (Phase 1)Active Not RecruitingNCT00669734
What this trial is testing

Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaPancreatic Acinar Cell CarcinomaPancreatic Ductal Adenocarcinoma+2 more
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Active Not RecruitingNCT03899636
What this trial is testing

A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

Who this might be right for
Stage III Pancreatic Cancer
Angiodynamics, Inc. 528
Not applicableUnknownNCT00079365
What this trial is testing

Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
University of South Florida
Testing effectiveness (Phase 2)Study completedNCT01939665
What this trial is testing

PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma

Who this might be right for
Locally Advanced Pancreatic Carcinoma (LAPC)Non-metastasized Unresectable Pancreatic CarcinomaPancreatic Cancer
Amsterdam UMC, location VUmc 50
Early research (Phase 1)WithdrawnNCT02868632
What this trial is testing

Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
NYU Langone Health
Large-scale testing (Phase 3)UnknownNCT00005869
What this trial is testing

Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Astex Pharmaceuticals, Inc.
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Early research (Phase 1)Study completedNCT01834170
What this trial is testing

EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma
University of Tehran 12
Testing effectiveness (Phase 2)UnknownNCT00346281
What this trial is testing

32P BioSiliconTM in Addition to Gemcitabine in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
pSiMedica Limited 15
Large-scale testing (Phase 3)Looking for participantsNCT07235930
What this trial is testing

Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer

Who this might be right for
Non-Resectable Pancreas Carcinoma
Zhejiang Cancer Hospital 292
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableActive Not RecruitingNCT04002479
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic Cancer+1 more
Alpha Tau Medical LTD. 37
Testing effectiveness (Phase 2)Ended earlyNCT01318642
What this trial is testing

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma of the PancreasLocally AdvancedUnresectable
NantBioScience, Inc. 10
Early research (Phase 1)Ended earlyNCT01739439
What this trial is testing

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IIB Pancreatic Cancer+1 more
Fox Chase Cancer Center 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07752875
What this trial is testing

LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation

Who this might be right for
Ovarian CancerSmall Cell Lung CancerNon Small Cell Lung Cancer+7 more
LG Chem 250
Early research (Phase 1)Study completedNCT00375310
What this trial is testing

Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Indiana University 27
Not applicableStudy completedNCT02282059
What this trial is testing

The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors

Who this might be right for
Pancreatic Neuroendocrine Tumors
Pfizer 100
Next Page